Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence

Archives of General Psychiatry

Volumn 67, Issue 6, 2010, Pages 632-644

  Ersche, Karen D ^a,b   Bullmore, Edward T ^a,b,d   Craig, Kevin J ^b,c,f   Shabbir, Shaila S ^d   Abbott, Sanja ^b,c   Müller, Ulrich ^a,b   Ooi, Cinly ^a,b   Suckling, John ^a,b   Barnes, Anna ^a,b   Sahakian, Barbara J ^a   Merlo Pich, Emilio V ^e   Robbins, Trevor W ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e GSK   (Italy)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; AMPHETAMINE; COCAINE; DOMPERIDONE; PLACEBO; PRAMIPEXOLE;

ADULT; ARTICLE; ASSOCIATION; ATTENTION; BRAIN FUNCTION; BRAIN REGION; CEREBELLUM CORTEX; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSIVENESS; MALE; MOOD; NAUSEA; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; STROOP TASK; SWEATING; TASK PERFORMANCE; VOMITING;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; BENZOTHIAZOLES; BIAS (EPIDEMIOLOGY); CEREBELLAR CORTEX; COCAINE-RELATED DISORDERS; COMPULSIVE BEHAVIOR; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ENGLAND; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INDIVIDUALITY; MAGNETIC RESONANCE IMAGING; MALE; PREFRONTAL CORTEX; QUESTIONNAIRES; RECEPTORS, DOPAMINE; STROOP TEST; SUBSTANCE-RELATED DISORDERS; SULPIRIDE;

EID: 77953310246     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.60     Document Type: Article

References (110)

1. United Nations Office on Drugs and Crime. World Drug Report 2007. New York, NY: United Nations Office on Drugs and Crime; 2007.
2. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369(9566):1047-1053.
3. European Monitoring Centre for Drugs and Drug Addiction. Cocaine and Crack Cocaine: A Growing Public Health Problem. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2007.
4. Sayre SL, Schmitz JM, Stotts AL, Averill PM, Rhoades HM, Grabowski JJ. Determining predictors of attrition in an outpatient substance abuse program. Am J Drug Alcohol Abuse. 2002;28(1):55-72.
5. de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M. Pharmacological treatment of cocaine dependence: a systematic review. Addiction. 2002;97(8): 931-949.
6. Kang SY, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J, Lipton DS. Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am J Psychiatry. 1991;148(5):630-635.
7. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-1652.
8. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(suppl 1):3-13.
9. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004; 16(4):456-464.
10. Verdejo-García A, Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl). 2007;190(4):517-530.
11. Verdejo-García AJ, Perales JC, Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav. 2007;32(5):950-966. (Pubitemid 46282289)
12. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, Tzilos G, Afshar M, Rouse ED, Tian H, Renshaw PF, Ciraulo DA, Yurgelun-Todd DA. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008;33(4):827-836.
13. Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry. 2008;64(11):998-1004.
14. Goldstein RZ, Volkow ND, Wang GJ, Fowler JS, Rajaram S. Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport. 2001;12(11):2595-2599. (Pubitemid 32682228)
15. Horner MD. Attentional functioning in abstinent cocaine abusers. Drug Alcohol Depend. 1999;54(1):19-33.
16. Toomey R, Lyons MJ, Eisen SA, Xian H, Chantarujikapong S, Seidman LJ, Faraone SV, Tsuang MT. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry. 2003;60(3):303-310. (Pubitemid 36307442)
17. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl). 2006;188(2):162-170. (Pubitemid 44371154)
18. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res. 2002; 111(1):65-74.
19. Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T, Telang F, Alia-Klein N, Volkow ND. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience. 2007; 144(4):1153-1159. (Pubitemid 46123821)
20. Hester R, Dixon V, Garavan H. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug Alcohol Depend. 2006;81(3):251-257. (Pubitemid 43152451)
21. Carpenter KM, Schreiber E, Church S, McDowell D. Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addict Behav. 2006;31(1):174-181. (Pubitemid 41790462)
22. Vadhan NP, Carpenter KM, Copersino ML, Hart CL, Foltin RW, Nunes EV. Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse. 2007;33(5): 727-736.
23. Copersino ML, Serper MR, Vadhan N, Goldberg BR, Richarme D, Chou JC, Stitzer M, Cancro R. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Res. 2004;128(3):209-218. (Pubitemid 39490840)
24. Lubman DI, Yucel M, Pantelis C. Addiction, a condition of compulsive behaviour? neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction. 2004;99(12):1491-1502. (Pubitemid 39664821)
25. Cox WM, Hogan LM, Kristian MR, Race JH. Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome. Drug Alcohol Depend. 2002; 68(3):237-243.
26. Marissen MAE, Franken IHA, Waters AJ, Blanken P, van den Brink W, Hendriks VM. Attentional bias predicts heroin relapse following treatment. Addiction. 2006; 101(9):1306-1312.
27. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH. Attentional bias predicts outcome in smoking cessation. Health Psychol. 2003; 22(4):378-387.
28. Franken IHA, Hendriks VM, Stam CJ, Van den Brink W. A role for dopamine in the processing of drug cues in heroin dependent patients. Eur Neuropsychopharmacol. 2004;14(6):503-508.
29. Hitsman B, MacKillop J, Lingford-Hughes A, Williams TM, Ahmad F, Adams S, Nutt DJ, Munafò MR. Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl). 2008;196(4):611-621.
30. Munafò MR, Mannie ZN, Cowen PJ, Harmer CJ, McTavish SB. Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers. J Psychopharmacol. 2007;21 (8):805-814.
31. Horvitz JC. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 2000;96(4):651-656.
32. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36(2):241-263.
33. Ungless MA. Dopamine: the salient issue. Trends Neurosci. 2004;27(12):702-706.
34. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci. 2006;26(24):6583-6588.
35. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasić JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology. 2006;31(12):2716-2727.
36. Martinez D, Kim JH, Krystal J, Abi-Dargham A. Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clin N Am. 2007;17(4):539-555.
37. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004;9(6):557-569.
38. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007;64(11):1575-1579.
39. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP. Decreased dopamine-D(2) receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14(2):169-177.
40. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N. Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001;158(12):2015-2021.
41. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M, Frankel WG. Cocaine dependence and D-2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology. 2004;29(6):1190-1202.
42. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D, et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry. 1990;147(6):719-724.
43. Everitt BJ, Hutcheson DM, Ersche KD, Pelloux Y, Dalley JW, Robbins TW. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann N Y Acad Sci. 2007;1121:576-597.
44. Amato L, Minozzi S, Pani PP, Davoli M. Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev. 2007;(3):CD006306.
45. Soares BG, Lima MS, Reisser AA, Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev. 2003;(2):CD003352.
46. Grabowski J, Shearer J, Merrill J, Negus SS. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav. 2004;29 (7):1439-1464. (Pubitemid 39172183)
47. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus. 2008;29 (3):31-49.
48. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783-1793.
49. Moeller FG, Dougherty DM, Barratt ES, Oderinde V, Mathias CW, Harper RA, Swann AC. Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002; 68(1):105-111. (Pubitemid 34880044)
50. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10(3):318-325.
51. Cools R, Sheridan M, Jacobs E, D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci. 2007;27(20):5506-5514. (Pubitemid 46790174)
52. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315(5816): 1267-1270.
53. Robbins TW, Everitt BJ. A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology (Berl). 2007;191(3): 433-437.
54. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8(11):1481-1489.
55. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009;14(1):22-31.
56. Dawe S, Loxton NJ. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev. 2004;28(3):343-351.
57. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403-1413.
58. Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol. 2006;59(5):852-858. (Pubitemid 43673163)
59. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
60. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
61. Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM. Pramipexole binding and activation of cloned and expressed dopamine D-2, D-3 and D-4 receptors. Eur J Pharmacol. 1995;290(1):29-36.
62. Franken IH, Hendriksa VM, van den Brink W. Initial validation of two opiate craving questionnaires: the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict Behav. 2002;27(5):675-685.
63. Franken IHA, Kroon LY, Hendriks VM. Influence of individual differences in craving and obsessive cocaine thoughts on attentional processes in cocaine abuse patients. Addict Behav. 2000;25(1):99-102.
64. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011.
65. Compton RJ, Banich MT, Mohanty A, Milham MP, Herrington J, Miller GA, Scalf PE, Webb A, Heller W. Paying attention to emotion: an fMRI investigation of cognitive and emotional Stroop tasks. Cogn Affect Behav Neurosci. 2003; 3(2):81-96.
66. Phaf RH, Kan KJ. The automaticity of emotional Stroop: a meta-analysis. J Behav Ther Exp Psychiatry. 2007;38(2):184-199.
67. Waters AJ, Sayette MA, Franken IHA, Schwartz JE. Generalizability of carry-over effects in the emotional Stroop task. Behav Res Ther. 2005;43(6):715-732. (Pubitemid 40693697)
68. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, van Balkom AJ, van Oppen P, van Dyck R. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry. 2005;62(8):922-933. (Pubitemid 41126887)
69. Malhi GS, Lagopoulos J, Sachdev PS, Ivanovski B, Shnier R. An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord. 2005; 7(suppl 5):58-69. (Pubitemid 43013462)
70. Mitterschiffthaler MT, Williams SCR, Walsh ND, Cleare AJ, Donaldson C, Scott J, Fu CH. Neural basis of the emotional Stroop interference effect in major depression. Psychol Med. 2008;38(2):247-256. (Pubitemid 351156593)
71. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corp; 1996.
72. Bullmore E, Long C, Suckling J, Fadili J, Calvert G, Zelaya F, Carpenter TA, Brammer M. Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Hum Brain Mapp. 2001;12(2):61-78.
73. Suckling J, Davis MH, Ooi O, Wink AM, Fadili J, Salvador R, Welchew D, Sendur L, Maxim V, Bullmore ET. Permutation testing of orthogonal factorial effects in a language-processing experiment using fMRI. Hum Brain Mapp. 2006; 27(5):425-433.
74. Bullmore ET, BrammerMJ, Rabe-Hesketh S, Curtis VA, Morris RG, Williams SC, Sharma T, McGuire PK. Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp. 1999;7(1):38-48. (Pubitemid 28546036)
75. Glover GH. Deconvolution of impulse response in event-related BOLD fMRI1. Neuroimage. 1999;9(4):416-429.
76. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995;51(6):768-774.
77. Montgomery SA, Asberg M. New depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
78. Nelson HE. National Adult Reading Test Manual. Windsor, England: NFER-Nelson; 1982.
79. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273-289.
80. Hester R, Garavan H. Neural mechanisms underlying drug-related cue distraction in active cocaine users. Pharmacol Biochem Behav. 2009;93(3):270-277.
81. Fadardi JS, Cox WM. Alcohol attentional bias: drinking salience or cognitive impairment? Psychopharmacology (Berl). 2006;185(2):169-178.
82. Stetter F, Ackermann K, Bizer A, Straube ER, Mann K. Effects of disease-related cues in alcoholic inpatients-results of a controlled alcohol Stroop study. Alcohol Clin Exp Res. 1995;19(3):593-599.
83. Bremner JD, Vermetten E, Vythilingam M, Afzal N, Schmahl C, Elzinga B, Charney DS. Neural correlates of the classic color and emotional Stroop in women with abuse-related posttraumatic stress disorder. Biol Psychiatry. 2004; 55(6):612-620.
84. Sim ME, Lyoo IK, Streeter CC, Covell J, Sarid-Segal O, Ciraulo DA, Kim MJ, Kaufman MJ, Yurgelun-Todd DA, Renshaw PF. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology. 2007;32(10):2229-2237.
85. Egner T, Hirsch J. The neural correlates and functional integration of cognitive control in a Stroop task. Neuroimage. 2005;24(2):539-547.
86. Rocca MA, Valsasina P, Ceccarelli A, Absinta M, Ghezzi A, Riccitelli G, Pagani E, Falini A, Comi G, Scotti G, Filippi M. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp. 2009;30(1):276-290.
87. Demb JB, Desmond JE, Wagner AD, Vaidya CJ, Glover GH, Gabrieli JD. Semantic encoding and retrieval in the left inferior prefrontal cortex: a functional MRI study of task difficulty and process specificity. J Neurosci. 1995;15 (9):5870-5878.
88. Thompson-Schill SL, D'Esposito M, Aguirre GK, Farah MJ. Role of left inferior prefrontal cortex in retrieval of semantic knowledge: a re-evaluation. Proc Natl Acad Sci U S A. 1997;94(26):14792-14797.
89. Badre D, Wagner AD. Left ventrolateral prefrontal cortex and the cognitive control of memory. Neuropsychologia. 2007;45(13):2883-2901.
90. Devlin JT, Matthews PM, Rushworth MFS. Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci. 2003;15(1):71-84.
91. Gabrieli JDE, Poldrack RA, Desmond JE. The role of left prefrontal cortex in language and memory. Proc Natl Acad Sci U S A. 1998;95(3):906-913.
92. Poldrack RA, Wagner AD, Prull MW, Desmond JE, Glover GH, Gabrieli JDE. Functional specialization for semantic and phonological processing in the left inferior prefrontal cortex. Neuroimage. 1999;10(1):15-35.
93. Shin LM, Whalen PJ, Pitman RK, Bush G, Macklin ML, Lasko NB, Orr SP, McInerney SC, Rauch SL. An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol Psychiatry. 2001;50(12):932-942.
94. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000;157(11): 1789-1798.
95. Kilts CD, Gross RE, Ely TD, Drexler KPG. The neural correlates of cue-induced craving in cocaine-dependent women. Am J Psychiatry. 2004;161 (2):233-241.
96. Volkow ND, Wang GJ, Ma YM, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003;23(36):11461-11468.
97. Narendran R, Martinez D. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse. 2008;62(11):851-869.
98. Maj J, Rogoz Z, Skuza G, Kolodziejczyk K. The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol. 1997;324(1): 31-37. (Pubitemid 27160905)
99. Cannon WB. The emergency function of the adrenal medulla in pain and major emotions. Am J Physiol. 1914;33:356-372.
100. Mierau J, Schingnitz G. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine-D2 receptor agonist. Eur J Pharmacol. 1992;215(2-3):161-170.
101. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56(suppl 1): 3-8.
102. Seeman P. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Synapse. 2009;63(3):186-192.
103. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001;2(10):695-703.
104. Tiffany ST. A cognitive model of drug urges and drug-use behavior-role of automatic and nonautomatic processes. Psychol Rev. 1990;97(2):147-168.
105. Munafò M, Mogg K, Roberts S, Bradley BP, Murphy M. Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task. J Psychopharmacol. 2003;17(3):310-316.
106. Field M. Cannabis 'dependence' and attentional bias for cannabis-related words. Behav Pharmacol. 2005;16(5-6):473-476.
107. Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A, Matarrese M, Carpinelli A, Bellodi L, Fazio F. In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage. 2008;42(1):306-314.
108. Olver JS, O'Keefe G, Jones GR, Burrows GD, Tochon-Danguy HJ, Ackermann U, Scott A, Norman TR. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. J Affect Disord. 2009;114(1-3): 321-326.
109. Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HGM. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry. 2004;55(10):1041-1045.
110. Burns GL, Keortge SG, Formea GM, Sternberger LG. Revision of the Padua Inventory of obsessive compulsive disorder symptoms: distinctions between worry, obsessions, and compulsions. Behav Res Ther. 1996;34(2):163-173.